23.07
1.03%
-0.24
After Hours:
23.07
Evolent Health Inc stock is currently priced at $23.07, with a 24-hour trading volume of 2.21M.
It has seen a -1.03% decreased in the last 24 hours and a -22.17% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $23.33 pivot point. If it approaches the $22.98 support level, significant changes may occur.
Previous Close:
$23.31
Open:
$23.46
24h Volume:
2.21M
Market Cap:
$2.65B
Revenue:
$1.96B
Net Income/Loss:
$-113.04M
P/E Ratio:
-22.62
EPS:
-1.02
Net Cash Flow:
$113.84M
1W Performance:
-5.68%
1M Performance:
-22.17%
6M Performance:
-21.34%
1Y Performance:
-32.23%
Evolent Health Inc Stock (EVH) Company Profile
Name
Evolent Health Inc
Sector
Industry
Phone
571-389-6000
Address
800 North Glebe Road, Suite 500, Arlington
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-03-24 | Initiated | Barclays | Overweight |
Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
Oct-16-23 | Initiated | UBS | Buy |
Apr-12-23 | Initiated | Stephens | Overweight |
Nov-01-22 | Initiated | Truist | Hold |
Jul-29-22 | Initiated | RBC Capital Mkts | Outperform |
Mar-30-22 | Initiated | Guggenheim | Buy |
Nov-18-21 | Upgrade | JP Morgan | Neutral → Overweight |
Apr-29-21 | Resumed | JP Morgan | Neutral |
Jan-07-21 | Initiated | BTIG Research | Buy |
Jul-06-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
Jun-05-20 | Downgrade | Goldman | Buy → Neutral |
Jun-02-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
Oct-05-18 | Resumed | Leerink Partners | Outperform |
Jun-04-18 | Initiated | Piper Jaffray | Overweight |
Apr-24-18 | Resumed | JP Morgan | Neutral |
Sep-20-17 | Initiated | KeyBanc Capital Mkts | Overweight |
Jun-02-17 | Initiated | Robert W. Baird | Outperform |
Mar-14-17 | Initiated | Oppenheimer | Outperform |
Jan-13-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
Oct-28-16 | Resumed | JP Morgan | Overweight |
Aug-05-16 | Reiterated | FBR Capital | Outperform |
Jul-26-16 | Initiated | Jefferies | Buy |
Jul-13-16 | Reiterated | FBR Capital | Outperform |
Mar-29-16 | Initiated | FBR Capital | Outperform |
Jan-06-16 | Initiated | Canaccord Genuity | Buy |
Jun-30-15 | Initiated | Goldman | Buy |
Jun-30-15 | Initiated | JP Morgan | Overweight |
Jun-30-15 | Initiated | Leerink Partners | Outperform |
Jun-30-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Evolent Health Inc Stock (EVH) Latest News
Evolent Health (NYSE:EVH) Hits New 12-Month Low at $23.29 - MarketBeat
MarketBeat
Evolent Health (EVH) Surpasses Q2 Earnings and Revenue Estimates - Yahoo Singapore News
Yahoo Singapore News
Swiss National Bank Reduces Stock Position in Evolent Health, Inc. (NYSE:EVH) - Defense World
Defense World
Options Traders Expect Huge Moves in Evolent Health (EVH) Stock - Yahoo News UK
Yahoo News UK
Evolent Health, Inc. (NYSE:EVH) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
MarketBeat
Evolent Health, Inc. (NYSE:EVH) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Defense World
Evolent Health Inc Stock (EVH) Financials Data
Evolent Health Inc (EVH) Revenue 2024
EVH reported a revenue (TTM) of $1.96 billion for the quarter ending December 31, 2023, a +45.26% rise year-over-year.
Evolent Health Inc (EVH) Net Income 2024
EVH net income (TTM) was -$113.04 million for the quarter ending December 31, 2023, a -489.86% decrease year-over-year.
Evolent Health Inc (EVH) Cash Flow 2024
EVH recorded a free cash flow (TTM) of $113.84 million for the quarter ending December 31, 2023, a +328.07% increase year-over-year.
Evolent Health Inc (EVH) Earnings per Share 2024
EVH earnings per share (TTM) was -$1.27 for the quarter ending December 31, 2023, a -535.00% decline year-over-year.
Evolent Health Inc Stock (EVH) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Blackley Seth | Chief Executive Officer |
Dec 05 '23 |
Sale |
26.54 |
141,000 |
3,741,475 |
637,645 |
Blackley Seth | Chief Executive Officer |
Dec 04 '23 |
Option Exercise |
0.00 |
280,000 |
0 |
778,645 |
McCarthy Daniel Joseph | PRESIDENT |
Nov 15 '23 |
Option Exercise |
10.65 |
3,000 |
31,950 |
201,333 |
McCarthy Daniel Joseph | PRESIDENT |
Nov 15 '23 |
Sale |
30.00 |
11,000 |
330,000 |
198,333 |
Rafferty Emily Ann | Chief Operating Officer |
Aug 15 '23 |
Sale |
28.05 |
7,900 |
221,595 |
70,897 |
Blackley Seth | Chief Executive Officer |
Jun 28 '23 |
Option Exercise |
3.84 |
33,011 |
126,762 |
816,022 |
Blackley Seth | Chief Executive Officer |
Jun 28 '23 |
Sale |
30.78 |
33,011 |
1,016,022 |
783,011 |
Blackley Seth | Chief Executive Officer |
Jun 16 '23 |
Option Exercise |
3.84 |
2,098 |
8,056 |
785,109 |
Blackley Seth | Chief Executive Officer |
Jun 16 '23 |
Sale |
30.16 |
2,098 |
63,276 |
783,011 |
Blackley Seth | Chief Executive Officer |
Jun 15 '23 |
Option Exercise |
3.84 |
75,931 |
291,575 |
858,942 |
About Evolent Health Inc
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates as a managed services firm that supports health systems and physician organizations in migration toward value-based care and population health management. Its services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services, and comprehensive health plan administration services. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
Cap:
|
Volume (24h):